Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Antibiotics (Basel, Switzerland)|October 30, 2020
Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosaChristian M Gill, Tomefa E Asempa, David P Nicolau
The Journal of Antimicrobial Chemotherapy|April 30, 2022
In vivo exposure-response relationship of meropenem against metallo-β-lactamase-harbouring Pseudomonas aeruginosa: an assessment using MICs from conventional and zinc-limited brothAbigail K Kois, David P Nicolau, Tomefa E Asempa
Open Forum Infectious Diseases|December 28, 2020
Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical TrialsTomefa E Asempa, Sergey Izmailyan, Kenneth Lawrence, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
In vivo activity of ceftibuten-ledaborbactam oral combination against serine-β-lactamase-producing Enterobacterales: an assessment in the pyelonephritis and cystitis murine modelChristina Koenig, Fan Yi, David P Nicolau, et al.
The Journal of Antimicrobial Chemotherapy|November 14, 2022
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feedingAliaa Fouad, Richard Quintiliani, David P Nicolau, et al.
Microbiology Spectrum|April 4, 2022
Comparison of Zinc Concentrations in the Broth of Commercial Automated Susceptibility Testing Devices (Vitek 2, MicroScan, BD Phoenix, and Sensititre)Tomefa E Asempa, Christian M Gill, Vindana Chibabhai, et al.
Journal of Clinical Microbiology|May 7, 2024
Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant EnterobacteralesAliaa Fouad, Patricia J Simner, David P Nicolau, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2023
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48Tomefa E Asempa, Abigail K Kois, Christian M Gill, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2022
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48Tomefa E Asempa, Abigail K Kois, Christian M Gill, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2019
Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in a Neutropenic Murine Thigh Infection ModelTomefa E Asempa, Kamilia Abdelraouf, Teresa Carabeo, et al.
Pageof 5